Cns Pharmaceuticals Inc (NASDAQ:CNSP) currently has a daily average trading volume of 5.17M but it saw 3406596 shares traded in last market. With a market cap of 5.56M USD, the company’s current market price of $0.17 came rising about 4.22 while comparing to the previous closing price of $0.17. In past 52 weeks, the stock remained buoying in the range of price level as high as $137.50 and as low as $0.10. In the recent trading on the day, stock has struck highest price mark of $0.16 while lowest mark touched by it was $0.181.
Taking a look at 20-day trading activity of Cns Pharmaceuticals Inc (CNSP) gives us an average price of $0.2829, while its current price level is -99.87% below from 52-week high level whereas it is 81.15% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.1158 while that of 200 days or SMA-200 reads an average of $27.4691. A closer look into the stock’s movement over the week reveals that its volatility is standing at 27.35% during that period while stretching the period over a month that increases to 32.89%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 22.58 which implies that the stock is in oversold territory.
Over the week, CNSP’s stock price is moving 22.70% up while it is -83.98% when we observe its performance for the past one month. Year-to-date it is -99.73% down and over the past year, the stock is showing a downside performance of -99.80%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -2.1 beat the consensus estimate of -3.3 for the same. The company is expected to be releasing its next quarterly report on 2024-Aug-15, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Cns Pharmaceuticals Inc’s total number of outstanding shares is 32.15M with 1.85% of that held by the insiders while 0.45% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -1018.78%. Stock’s beta reads 1.06. Its return on asset (ROA) is -358.12% on average.
